Hillsdale Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,085
Closed -$6.21M 671
2024
Q2
$6.21M Sell
15,085
-565
-4% -$224K 0.49% 38
2024
Q1
$6.32M Sell
15,650
-3,530
-18% -$1.24M 0.5% 35
2023
Q4
$5.88M Sell
19,180
-620
-3% -$167K 0.48% 35
2023
Q3
$4.79M Sell
19,800
-200
-1% -$51.2K 0.44% 57
2023
Q2
$4.8M Sell
20,000
-5,800
-22% -$1.2M 0.44% 64
2023
Q1
$4.85M Buy
25,800
+50
+0.2% +$10.3K 0.42% 82
2022
Q4
$5.47M Buy
25,750
+100
+0.4% +$20K 0.46% 55
2022
Q3
$4.03M Hold
25,650
0.36% 106
2022
Q2
$3.84M Sell
25,650
-100
-0.4% -$14.5K 0.31% 124
2022
Q1
$4.21M Sell
25,750
-5,800
-18% -$956K 0.27% 130
2021
Q4
$6.87M Buy
31,550
+350
+1% +$73.3K 0.46% 51
2021
Q3
$5.91M Sell
31,200
-800
-3% -$146K 0.46% 52
2021
Q2
$5.65M Sell
32,000
-700
-2% -$121K 0.45% 52
2021
Q1
$5.37M Buy
32,700
+24,800
+314% +$3.79M 0.45% 62
2020
Q4
$1.1M Buy
+7,900
New +$996K 0.1% 200
2019
Q1
Sell
-39,600
Closed -$2.1M 651
2018
Q4
$2.1M Buy
39,600
+14,200
+56% +$780K 0.25% 84
2018
Q3
$1.52M Buy
+25,400
New +$1.39M 0.2% 107

Other funds holding MEDP

Hillsdale Investment Management's MEDP Position: Q3 2024 in Review

Hillsdale Investment Management sold out of Medpace (MEDP) in Q3 2024, closing a stake of 15,085 shares — an estimated $6.21M sold.

Hillsdale Investment Management first reported a position in MEDP in Q3 2018 and held it in 17 quarters. The position peaked at $6.87M in Q4 2021. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Hillsdale Investment Management reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 15,085 Medpace shares in Q3 2024, an estimated $6.21M.
  • Hillsdale Investment Management first reported a position in Medpace in Q3 2018 and held it in 17 quarters.
  • Hillsdale Investment Management's Medpace position peaked at $6.87M in Q4 2021.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Hillsdale Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.